Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2021-07-13
Original market date: See footnote 1
2016-07-20
Product name:
SODIUM NITRITE INJECTION, USP
Description:
10ML SINGLE USE VIAL
DIN:
02440466
Product Monograph/Veterinary Labelling:
Date:
2015-04-27
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
HOPE PHARMACEUTICALS LTD
170
422 Richards Street
Vancouver
British Columbia
Canada
V6B 2Z4
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
92:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V03AB08 SODIUM NITRITE
Active ingredient group (AIG) number:See footnote5
0104384004
Active ingredient(s) See footnote8 | Strength |
---|---|
SODIUM NITRITE | 30 MG / ML |